Acetazolamide-augmented blood-oxygen-level-dependent (ACZ-BOLD MRI) provides robust estimation of cerebrovascular reactivity (CVR). Past approaches are limited to extraction of terminal CVR at arbitrarily selected times in the pharmacologic response, due to low signal-to-noise characteristics. We previously introduced a computational framework that pre-conditions the BOLD response for dynamic analysis and extraction of maximal, rather than terminal augmentation profiles, and novel hemodynamic signatures such as ACZ-BOLD time-to-maxima (Tmax). Several consistent and sometimes paradoxical patterns have emerged, the presentation of which we considered timely for this potentially novel hemodynamic neuroimaging biomarker.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords